SILICONE TRACHEAL T-TUBES

K013321 · Technical Products, Inc. · BTR · Jun 4, 2002 · Anesthesiology

Device Facts

• Record ID: K013321
• Device Name: SILICONE TRACHEAL T-TUBES
• Applicant: Technical Products, Inc.
• Product Code: BTR · Anesthesiology
• Decision Date: Jun 4, 2002
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 868.5730
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

1. As a stent to aid in the rehabilitation of tracheal stenosis 2. As a stent to temporarily aid in laryngotracheal injuries 3. To support a Reconstituted Trachea 4. As a stent to provide an airway for a cervical trachea that cannot be repaired

Device Story

Silicone Tracheal T-Tube functions as an indwelling airway stent. Device provides structural support to the trachea; maintains airway patency in cases of stenosis, injury, or reconstruction. Used by clinicians in hospital or surgical settings. Inserted into the trachea to prevent collapse or obstruction; facilitates healing or provides long-term airway management where surgical repair is not feasible. Device is a passive mechanical implant; no active components or software.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Silicone tracheal T-tube; passive mechanical implant; dimensions and form factor designed for tracheal insertion; biocompatible silicone material.

Indications for Use

Indicated for patients requiring tracheal stenting for rehabilitation of tracheal stenosis, temporary support for laryngotracheal injuries, support for a reconstituted trachea, or airway maintenance for unrepaired cervical trachea.

Regulatory Classification

Identification

A tracheal tube is a device inserted into a patient's trachea via the nose or mouth and used to maintain an open airway.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the seal of the Department of Health & Human Services USA. The seal features a stylized eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle.

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 9200 Corporate Boulevard . Rockville MD 20850

Technical Products, Inc. c/o Norbert Thomson, President 2416 Park Central Boulevard Decatur. Georgia 30035

Re: K013321

Trade/Device Name: Silicone Tracheal T-Tube Regulation Number: 868.5730 Regulation Name: Tracheal Tube Regulatory Class: Class II Product Code: BTR Dated: May 9, 2002 Received: May 10, 2002

Dear Mr. Thomson:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced aboye and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

JUN 0 4 2002

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{1}------------------------------------------------

Page 2 - Norbert Thomson, President

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

A. Ralph Rosenthal

A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

{2}------------------------------------------------

510 (k) Number (if known):

K 013321

Tracheal/Thoracic T-Tube Device Name:

Indications for Use:

1. As a stent to aid in the rehabilitation of tracheal stenosis

2. As a stent to temporarily aid in laryngotracheal injuries

3. To support a Reconstituted Trachea

4. As a stent to provide an airway for a cervical trachea that cannot be repaired

Prescription Use (Per 21 CFR 801.109)

Anatolut

(Division Sign-Off) Division of Ophthalmic Ear, Nose and Throat Devises

KO133. 510(k) Number